ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
People with type 1 diabetes struggle to produce insulin because their immune system attacks cells in the pancreas that make the sugar-regulating hormone. A team of researchers has designed functionalized nanoparticles that can reprogram immune cells in diabetic mice to stop assaulting the insulin-producing cells (Sci. Signaling 2016, DOI: 10.1126/scisignal.aad0612). To reestablish what’s called immune tolerance for pancreatic cells, Francisco J. Quintana of Harvard Medical School and coworkers decorated gold nanoparticles with two molecules: insulin and 2-(1´-H-indole-3´-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE). Once immune cells called dendritic cells take up the nanoparticles, ITE activates a transcription factor that turns on pathways involved in releasing signaling molecules directed at T cells. These molecules stop damage-inducing inflammation by telling T cells to stand down. The insulin molecules carried by the gold particles help target the dendritic cells’ message toward T cells attacking pancreatic cells. When the team injected the nanoparticles into mice that can develop type 1 diabetes spontaneously, about 25% of the animals became diabetic. For untreated mice, the incidence was about 75%. Quintana thinks similar particles could be designed for other autoimmune diseases such as multiple sclerosis.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter